Editorial: Growth hormone replacement therapy and insulin sensitivity

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 4, 2003, Pages 1453-1454

  Svensson, Johan ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOGEN SYNTHASE; HUMAN GROWTH HORMONE; INSULIN;

ADULT; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EDITORIAL; FEMALE; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKELETAL MUSCLE; TREATMENT OUTCOME; BLOOD; LIPID PEROXIDATION; NOTE;

ADULT; FATTY ACIDS, NONESTERIFIED; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION;

EID: 0037809349     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030218     Document Type: Editorial

References (23)

1. Johansson J-O, Fowelin J, Landin K, Lager I, Bengtsson B-Å 1995 Growth hormone-deficient adults are insulin-resistant. Metabolism 44:1126-1129
2. Hew F, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G, Beck-Nielsen H, Alford F 1996 Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 81:555-564
3. O'Neal D, Kalfas A, Dunning P, Christopher MJ, Sawyer SD, Ward GM, Alford FA 1994 The effects of 3 months treatment of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults. A minimal model analysis. J Clin Endocrinol Metab 79:975-983
4. Fowelin J, Attvall S, Lager I, Bengtsson B-Å 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443-1447
5. Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L 2003 Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 88:000-0000
6. Götherström G, Svensson J, Koranyi J, Alpsten M, Bosæus I, Bengtsson B-Å, Johannsson G 2001 A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86:4657-4665
7. Hernberg-Ståhl E, Luger A, Abs R, Bengtsson B-Å, Feldt-Rasmussen U, Wilton P, Westberg B, Monson JP 2001 Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab 86:5277-5281
8. Weaver J, Monson J, Noonan K, John WG, Edwards A, Evans KA, Cunningham J 1995 The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153-159
9. Rosenfalck A, Maghsoudi S, Fisker S, Jørgensen JOL, Christiansen JS, Hilsted J, Vølund AA, Madsbad S 2000 The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab 85:4173-4181
10. Al-Shoumer K, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston DG 1998 Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) 48:795-802
11. Bûlow B, Erfurth E 1999 A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance. Clin Endocrinol (Oxf) 50:45-55
12. Christopher M, Hew F, Oakley M, Rantzau C, Alford F 1998 Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 83:1668-1681
13. Hwu C-M, Kwok C, Lai T-Y, Lee T-S, Hsiao L-C, Lee S-H, Fang VS, Ho L-T 1997 Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience, J Clin Endocrinol Metab 82:3285-3292
14. Jørgensen JO, Vahl N, Nyholm B, Juul A, Müller J, Møller N, Schmitz O, Skakkebæk NE, Christiansen JS 1996 Substrate metabolism and insulin sensitivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults. Endocrinol Metab 3:281-286
15. Svensson J, Fowelin J, Landin K, Bengtsson B-Å, Johansson J-O 2002 Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 87:2121-2127
16. Bengtsson B-Å, Abs R, Feldt-Rasmussen U, Goth M, Monson J, Thunander M, Koltowska-Häggström M, Mattsson A, Wilton P 2002 The risk of diabetes mellitus in hypopituitary patients on growth hormone substitution. Growth Horm IGF Res 12:302-303 (Abstract 233)
17. Randle P, Garland P, Hales C, Newsholme E 1963 The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
18. Nielsen S, Møller N, Christiansen JS, Jørgensen JO 2001 Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301-2308
19. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop L 2001 Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 86:5813-5818
20. Nielsen S, Møller N, Pedersen S, Christiansen JS, Jørgensen JO 2002 The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults. J Clin Endocrinol Metab 87:3274-3278
21. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen, Møller J, Skakkebæk NE, Christiansen JS 1989 Beneficial effect of growth hormone treatment in GH-deficient adults. Lancet i:1221-1225
22. Salomon F, Cuneo R, Hesp R, Sönksen P 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
23. Johannsson G, Rosén T, Bengtsson B-Å 1997 Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf) 47571-581